- Home
- CSTM vs CNTA Comparison
CSTM vs CNTA Comparison
Compare CSTM & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSTM | CNTA |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | France | United Kingdom |
| Employees | 11500 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.5B |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CSTM | CNTA |
|---|---|---|
| Price | $29.60 | $39.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $29.00 | ★ $42.00 |
| AVG Volume (30 Days) | 2.2M | ★ 4.2M |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 405.26 | 29.13 |
| EPS | ★ 1.92 | N/A |
| Revenue | ★ $8,449,000,000.00 | $15,000,000.00 |
| Revenue This Year | $21.45 | N/A |
| Revenue Next Year | $0.62 | N/A |
| P/E Ratio | $15.37 | ★ N/A |
| Revenue Growth | ★ 15.19 | N/A |
| 52 Week Low | $8.09 | $10.95 |
| 52 Week High | $30.14 | $40.26 |
Technical Indicators
Market Signals| Indicator | CSTM | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 66.80 | 76.90 |
| Support Level | $13.79 | $24.80 |
| Resistance Level | N/A | $40.26 |
| Average True Range (ATR) | 1.29 | 1.07 |
| MACD | 0.54 | 0.80 |
| Stochastic Oscillator | 93.18 | 96.49 |
Price Performance
Historical ComparisonAbout CSTM Constellium SE (France)
Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.